Clinical Trials Browser

Phase 2 × Malignant Tumor of Ill-defined Site × Clear all

NCT02542397 2022-11-03

LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients

Phase 2 Terminated

75 enrolled 12 charts

Malignant Tumor of Ill-defined Site